Scioto Biosciences
Plug and Play · Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 PeptobioticsShared: livestock healthNot statedOther | Other | Not stated | EF2020 |
 MELLOShared: developing innovative, probiotic, healthNot statedOther | Other | Not stated | Plug and Play |
 Grannus TherapeuticsShared: developing innovative, preclinical, therapeuticNot statedOther | Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Toregem Bio Pharma Co., Ltd.Shared: pioneering health, transformative, therapyNot statedOther | Other | Not stated | Plug and Play |
 Omnispirant LimitedShared: innovative therapy, therapeutic, proprietaryNot statedAI | AI | Not stated | Plug and Play |
 Modella AIShared: pioneering health, therapeutic, developingAcquiredAI | AI | Acquired | Plug and Play |
 AgrivannaShared: livestock healthNot statedAI | AI | Not stated | Plug and Play |
 KimamaniShared: pioneering health, impact, developingNot statedOther | Other | Not stated | Plug and Play |
Also from Plug and Play
All of Plug and Play
Programs
| Program | Cohort | Source |
|---|---|---|
 Plug and Play | Not stated | Plug and Play Page |
About Scioto Biosciences
"Scioto Biosciences is a pioneering health and lifetech company focused on developing innovative therapies with a transformative impact on microbiome therapeutics. Founded in 2017 and headquartered in Indianapolis, Indiana, Scioto Biosciences is dedicated to revolutionizing the delivery of microbiome-based treatments. At the core of their mission is the Scioto Platform, designed to enhance the efficacy of probiotics in various applications, including diabetes, neurological disorders, gastrointestinal health, and livestock health. Central to Scioto's advancements is their proprietary Activated Bacterial Therapeutics (ABT) platform, which optimizes the delivery and functionality of live bacterial therapeutics. Their lead product candidate, SB-121, utilizes this platform to target specific conditions like Autism Spectrum Disorder and necrotizing enterocolitis. In 2020, Scioto Biosciences secured a significant Series B investment from Genome & Company, a South Korean firm, further solidifying their position in the industry and expanding their developmental capabilities."
- Category
- Other
- Location
- United States
- Checked
- 3h ago
Scioto Biosciences: questions
Which accelerators did Scioto Biosciences go through?
Scioto Biosciences is listed by Plug and Play.
Where is Scioto Biosciences based?
Scioto Biosciences lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.